In the second part of the CPhI Worldwide Annual Report it has been revealed that the trend towards the increased use of modern manufacturing processes and quality systems is occurring very slowly and the current drugs pipeline is discouraging.
Report
This second part, which focuses on the immediate and long-term trends in pharma manufacturing and ingredients, includes the expert opinions of Emil Ciurczak, president at Doramaxx Consulting; Brian Carlin, the excipients iconoclast, and Girish Malhotra, president at EPCOT International.